United States Gene Therapy Market Overview

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Size in 2024: US$ 1,312.2 Million 

Market Forecast in 2033: US$ 3,697.8 Million

Market Growth Rate (2025-2033): 12.1%

The United States gene therapy market size was valued at USD 1,312.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 3,697.8 Million by 2033, exhibiting a CAGR of 12.1% from 2025-2033.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/united-states-gene-therapy-market/requestsample

United States Gene Therapy Market Industry Trends and Drivers:

The United States gene therapy market is experiencing rapid expansion, driven by groundbreaking advancements in genetic research, increasing investment in biotechnology, and a growing prevalence of genetic disorders. The healthcare industry is witnessing a paradigm shift as gene therapy emerges as a transformative solution for rare and complex diseases. The rising demand for personalized medicine is encouraging pharmaceutical and biotech companies to develop targeted therapies that offer long-term efficacy and minimal side effects. Regulatory authorities are actively streamlining approval pathways to accelerate the commercialization of innovative gene therapies, fostering a favorable business environment. Additionally, collaborations between research institutions and industry players are enhancing clinical trial success rates, further strengthening the market’s growth trajectory.

Key drivers propelling the United States gene therapy market include the increasing incidence of genetic disorders such as hemophilia, muscular dystrophy, and cystic fibrosis, necessitating advanced treatment solutions. The expanding applications of gene therapy across oncology, ophthalmology, and neurology are significantly enhancing its market potential. Continuous advancements in viral vector technology and gene-editing techniques are improving the precision and efficiency of therapeutic interventions, making gene therapy a viable option for previously untreatable conditions. Furthermore, government initiatives supporting biomedical research and favorable reimbursement policies are incentivizing the development and adoption of gene therapies. The rising preference for one-time curative treatments over traditional chronic disease management solutions is further fueling market expansion.

The evolving landscape of the United States gene therapy market is presenting lucrative opportunities for stakeholders, with a strong pipeline of novel therapies expected to gain regulatory approvals in the coming years. Biopharmaceutical firms are increasingly engaging in strategic partnerships, mergers, and acquisitions to accelerate product innovation and market penetration. The integration of artificial intelligence and big data analytics in genomic research is streamlining drug discovery processes, enhancing treatment efficacy, and reducing development timelines. As advancements in gene delivery systems continue to improve safety profiles, patient acceptance of gene therapies is steadily increasing. With sustained research funding, technological innovations, and supportive regulatory frameworks, the market is poised to achieve substantial long-term growth, reinforcing its critical role in shaping the future of precision medicine.

United States Gene Therapy Market Industry Trends and Drivers:

Analysis by Gene Type:

• Antigen
• Cytokine
• Tumor Suppressor
• Suicide Gene
• Deficiency
• Growth Factors
• Receptors
• Others

Analysis by Vector Type:

• Viral Vector 
  • Adenoviruses
  • Lentiviruses
  • Retroviruses
  • Adeno-Associated Virus
  • Herpes Simplex Virus
  • Poxvirus
  • nia ViruVaccis
  • Others
•  Non-Viral Techniques
  • Naked and Plasmid Vectors
  • Gene Gun
  • Electroporation
  • Lipofection
  • Others

Analysis by Delivery Method:

• In-Vivo Gene Therapy
• Ex-Vivo Gene Therapy

Analysis by Application:

• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Disease
• Others

Breakup by Region:

• Northeast
• Midwest
• South
• West

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=11240&flag=C

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145